Distro — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free
Sperogenix Therapeutics 曙方医药
sperogenix therapeutics is a platform company dedicated to developing and commercializing rare disease therapeutics in china with focus on mid-to-late clinical stage and commercial stage products. with prioritized therapeutic areas, such as pulmonary vascular disorders, neurological disorders, inherited metabolic diseases, and non-oncology hematology disorders, sperogenix is dedicated to establishing an innovative commercial model tailored to the china rare disease field, in order to provide affordable and reliable products and services to chinese physicians and patients. sperogenix was founded in 2019 and is backed by biopharma industry blue chip investors including lilly asia ventures (lav) and morningside venture in the a-round financing.
Frequently asked questions about Sperogenix Therapeutics 曙方医药
Let us help answer the most common questions you might have.
What is Sperogenix Therapeutics 曙方医药's official website?
Sperogenix Therapeutics 曙方医药's official website is sperogenix.com
How many employees does Sperogenix Therapeutics 曙方医药 have?
Sperogenix Therapeutics 曙方医药 has 7 employees
What industry does Sperogenix Therapeutics 曙方医药 belong to?
Sperogenix Therapeutics 曙方医药 is in the industry of: Pharmaceuticals
What are Sperogenix Therapeutics 曙方医药's social media links?
Sperogenix Therapeutics 曙方医药 Linkedin page
Distro — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free
